New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2014
08:02 EDTABAXAbaxis receives Health Canada Class III approval for Piccolo Xpress
Abaxis announced Health Canada approved the Piccolo Xpress and Piccolo Reagent Discs as a Class III medical device for use throughout Canada. With this reclassification, Canadian healthcare providers and patients can now enjoy the benefits of lab-accurate blood chemistry diagnostics at the point-of-care.
News For ABAX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 25, 2014
07:41 EDTABAXAbaxis price target raised to $64 from $60 at Canaccord
Subscribe for More Information
November 21, 2014
08:06 EDTABAXAbaxis acquires U.K.-based distribution organization
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use